We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Bladder Cancer

Journal Scan / Research · November 05, 2020

Neoadjuvant Gemcitabine–Cisplatin Plus Radical Cystectomy–Pelvic Lymph Node Dissection for Muscle-Invasive Bladder Cancer

Clinical Genitourinary Cancer

 

Additional Info

Clinical Genitourinary Cancer
Neoadjuvant Gemcitabine-Cisplatin Plus Radical Cystectomy-Pelvic Lymph Node Dissection for Muscle-Invasive Bladder Cancer: A 12-year Experience
Clin Genitourin Cancer 2020 Oct 01;18(5)387-394, G Iyer, CM Tully, EC Zabor, BH Bochner, G Dalbagni, HW Herr, SM Donat, P Russo, I Ostrovnaya, AM Regazzi, MI Milowsky, JE Rosenberg, DF Bajorin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading